M. Inada

机构：Kindai University

发表论文 20 篇 · 总被引 221 次 · h-index 6

代表论文

• Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells (2019 · PLoS ONE · 被引 55)
• Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses (2019 · Biochemical and Biophysical Research Communications · 被引 35)
• In�vitro anticancer effects of a RAGE inhibitor discovered using a structure-based drug design system (2018 · Oncology Letters · 被引 33)
• Effect of piceatannol-rich passion fruit seed extract on human glyoxalase I–mediated cancer cell growth (2019 · Biochemistry and Biophysics Reports · 被引 30)
• Immunological characterization and clinical implication of cobalamin binding protein in human gastric cancer. (1989 · PubMed · 被引 30)
• Anticancer Non-narcotic Opium Alkaloid Papaverine Suppresses Human Glioblastoma Cell Growth (2019 · Anticancer Research · 被引 28)